Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cerus Corp (NQ: CERS ) 1.890 +0.100 (+5.59%) Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Cerus Corp < Previous 1 2 3 Next > Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery March 20, 2024 On Wednesday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Block Inc (NYSE:SQ) amidst Bitcoin (CRYPTO: BTC) prices recovering. Via Benzinga Why Blood Components-Focused Cerus Stock Is Rising Tuesday March 19, 2024 Cerus reports results from the ReCePI Phase 3 trial for INTERCEPT Red Blood Cells, meeting the primary efficacy endpoint in cardiac surgery patients. The safety profile is also favorable. Expect FDA... Via Benzinga Exposures Product Safety Cathie Wood's Ark Invest Sells Coinbase Shares As Bitcoin Hits Yet Another All-Time New High, Buys Stock Of This Social Media Company March 13, 2024 On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Coinbase Global Inc (NASDAQ:COIN) and Pinterest Inc (NYSE:PINS). Via Benzinga Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday March 06, 2024 U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Cerus: Q4 Earnings Insights March 05, 2024 Via Benzinga Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 06, 2024 Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results. Via Benzinga CERS Stock Earnings: Cerus Beats EPS, Misses Revenue for Q4 2023 March 05, 2024 CERS stock results show that Cerus beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session March 05, 2024 Via Benzinga Cerus's Earnings: A Preview March 04, 2024 Via Benzinga Cerus Earnings Perspective: Return On Capital Employed May 18, 2023 Via Benzinga Recap: Cerus Q1 Earnings May 04, 2023 Via Benzinga Earnings Scheduled For March 5, 2024 March 05, 2024 Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. Via Benzinga Cerus's Return On Capital Employed Overview November 21, 2022 Via Benzinga GE HealthCare Technologies Posts Upbeat Earnings, Joins Toyota, Spotify And Other Big Stocks Moving Higher On Tuesday February 06, 2024 U.S. stocks traded mostly higher, with the Dow Jones gaining around 70 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought January 26, 2024 The widely followed growth investor keeps making moves. Via The Motley Fool 3 Growth Stocks That Could Go Parabolic in 2024 January 15, 2024 These innovation-oriented companies could take flight this year. Via The Motley Fool 12 Health Care Stocks Moving In Monday's Pre-Market Session November 06, 2023 Via Benzinga Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought June 07, 2023 The widely followed growth investor keeps making moves. Via The Motley Fool 7 Best Cathie Wood Stocks for Your May 2023 Buy List May 02, 2023 This year promises to be very different for Cathie Wood stocks, as signs of economic improvement become more prominent. Via InvestorPlace Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought March 09, 2023 The popular growth investor publishes her daily transactions. Cathie Wood keeps buying Tesla as well as some of her smaller holdings. Via The Motley Fool Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought January 19, 2023 The popular growth investor publishes her daily transactions. She keeps buying Tesla as well as some low-priced genetics specialists. Via The Motley Fool S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher January 09, 2023 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Monday. Via Benzinga Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 01, 2023 Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session January 09, 2023 Via Benzinga Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 09, 2023 Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash. Via Benzinga Nasdaq Surges Over 200 Points; Crude Oil Rises 2% January 09, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Monday. Via Benzinga Stocks That Hit 52-Week Lows On Monday January 09, 2023 Companies That Fell Through 52-Week Lows Monday During Monday's morning trading, 14 companies set new 52-week lows. Via Benzinga Class Of 1997: 25 Years Decades After Their IPOs, Where Are These Companies Now? May 19, 2022 Delivering on a promise is a tough proposition, and to consistently deliver requires excellence on all fronts. Via Benzinga Cerus's Return On Capital Employed Overview February 23, 2022 According to data from Benzinga Pro, during Q4, Cerus's (NASDAQ:CERS) reported sales totaled $39.87 million. Despite a 26.66% increase in earnings, the company posted a loss of $9... Via Benzinga Cerus Reports Narrower Quarterly Loss As INTERCEPT Platelet Kits Lift Q4 Sales February 23, 2022 Cerus Corp's (NASDAQ: CERS) Q4 FY21 product revenue was $39.9 million, compared to $28.2 million, driven by increased sales of INTERCEPT platelet kits to blood... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.